KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Peoples Bancorp (PEBO) Cash & Equivalents: 2016-2025

Historic Cash & Equivalents for Peoples Bancorp (PEBO) over the last 10 years, with Sep 2025 value amounting to $190.2 million.

  • Peoples Bancorp's Cash & Equivalents fell 32.95% to $190.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.2 million, marking a year-over-year decrease of 32.95%. This contributed to the annual value of $217.7 million for FY2024, which is 48.99% down from last year.
  • According to the latest figures from Q3 2025, Peoples Bancorp's Cash & Equivalents is $190.2 million, which was up 2.23% from $186.1 million recorded in Q2 2025.
  • In the past 5 years, Peoples Bancorp's Cash & Equivalents registered a high of $499.7 million during Q3 2021, and its lowest value of $15.0 million during Q4 2022.
  • Its 3-year average for Cash & Equivalents is $251.1 million, with a median of $217.7 million in 2024.
  • Per our database at Business Quant, Peoples Bancorp's Cash & Equivalents slumped by 70.94% in 2022 and then spiked by 2,742.73% in 2023.
  • Over the past 5 years, Peoples Bancorp's Cash & Equivalents (Quarterly) stood at $15.3 million in 2021, then dropped by 1.58% to $15.0 million in 2022, then soared by 2,742.73% to $426.7 million in 2023, then tumbled by 48.99% to $217.7 million in 2024, then crashed by 32.95% to $190.2 million in 2025.
  • Its Cash & Equivalents was $190.2 million in Q3 2025, compared to $186.1 million in Q2 2025 and $187.0 million in Q1 2025.